Journey Medical Corporation
DERM
$5.31
$0.061.14%
| Weiss Ratings | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.51 | |||
| Price History | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.31% | |||
| 30-Day Total Return | 9.71% | |||
| 60-Day Total Return | 9.94% | |||
| 90-Day Total Return | -0.19% | |||
| Year to Date Total Return | 32.75% | |||
| 1-Year Total Return | 41.98% | |||
| 2-Year Total Return | 255.61% | |||
| 3-Year Total Return | 35.11% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -22.93% | |||
| 52-Week Low % Change | 86.32% | |||
| Price | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.89 | |||
| 52-Week Low Price | $2.85 | |||
| 52-Week Low Price (Date) | Mar 25, 2024 | |||
| 52-Week High Price (Date) | Oct 04, 2024 | |||
| Valuation | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 110.93M | |||
| Enterprise Value | 109.53M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.94 | |||
| Earnings Per Share Growth | 12.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.89 | |||
| Price/Book (Q) | 10.07 | |||
| Enterprise Value/Revenue (TTM) | 1.90 | |||
| Price | $5.31 | |||
| Enterprise Value/EBITDA (TTM) | -7.42 | |||
| Enterprise Value/EBIT | -6.08 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 20.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 480 434 6670 | |||
| Address | 9237 East Via de Ventura Boulevard Scottsdale, AZ 85258 | |||
| Website | journeymedicalcorp.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -31.18% | |||
| Profit Margin | -31.73% | |||
| Management Effectiveness | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -17.33% | |||
| Return on Equity | -- | |||
| Income Statement | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 57.77M | |||
| Total Revenue (TTM) | 57.77M | |||
| Revenue Per Share | $2.81 | |||
| Gross Profit (TTM) | 33.11M | |||
| EBITDA (TTM) | -14.76M | |||
| EBIT (TTM) | -18.02M | |||
| Net Income (TTM) | -18.34M | |||
| Net Income Avl. to Common (TTM) | -18.34M | |||
| Total Revenue Growth (Q YOY) | -57.64% | |||
| Earnings Growth (Q YOY) | -114.24% | |||
| EPS Diluted (TTM) | -0.94 | |||
| EPS Diluted Growth (Q YOY) | -115.00% | |||
| Balance Sheet | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 22.46M | |||
| Cash Per Share (Q) | $1.09 | |||
| Total Current Assets (Q) | 46.16M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 10.93M | |||
| Current Ratio (Q) | 1.385 | |||
| Book Value Per Share (Q) | $0.53 | |||
| Total Assets (Q) | 64.04M | |||
| Total Current Liabilities (Q) | 33.33M | |||
| Total Debt (Q) | 21.07M | |||
| Total Liabilities (Q) | 53.12M | |||
| Total Common Equity (Q) | 10.93M | |||
| Cash Flow | DERM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 25.58M | |||
| Net Change in Cash (TTM) | -2.29M | |||
| Levered Free Cash Flow (TTM) | -20.76M | |||
| Cash from Operations (TTM) | -27.87M | |||
